Faraday Future Q2: Massive losses, financing volatility and going-concern risk despite cash boost

Snapshot - Faraday Future Intelligent Electric Inc. (NASDAQ: PSAC) - Q2 2025

Quick summary (figures in the filing are presented in thousands)
* Revenue: $54 (Q2 2025) vs $293 (Q2 2024); six months: $370 vs $295.
* Cost of revenue: $26,912 (Q2 2025) - driving a gross loss of $(26,858). Six months cost: $48,293; gross loss $(47,923).
* Operating loss: $(48,108) (Q2); $(91,939) (six months).
* Net loss: $(124,676) (Q2 2025) vs $(108,685) (Q2 2024); six months: $(134,954) vs $(156,902).
* Net loss per share (basic): $(1.20) for Q2 2025; weighted average shares: 103,712,230 (Q2 2025).
* Cash on hand: $13,228 (June 30, 2025) up from $7,144 (Dec 31, 2024). Total assets: $399,723; total liabilities: $339,867; stockholders' equity: $59,856.
* Accumulated deficit: $(4,449,300). Inventory, net: $23,103. Customer deposits: ~$3,235 recorded in accrued liabilities.

What's happening inside the company - high level
* Production & product focus: continuing FF 91 manufacturing at Hanford and preparing FX Series (SuperOne and pipeline models). Deliveries remain extremely low (only a few vehicles delivered).
* Heavy financing activity: multiple SPA-style convertible note financings, issuance of warrants and incremental warrants; frequent conversions of debt into equity. The company uses fair-value accounting for many of its debt instruments, producing large non-cash volatility in earnings.
* Liquidity strategy: raising capital via SPA notes, warrants, a standby equity purchase agreement and an ATM program (recently regained eligibility). Management continues to pursue closings and subsequent financings (post-period borrowing noted in subsequent events).

Positive aspects (income statement & near-term finance)
* Cash increased to $13,228 (June 30, 2025) from $7,144 at year-end - shows recent financing traction.
* Revenue rose modestly on a six-month basis: $370 vs $295 year-over-year (up 25.4%), reflecting early leasing activity and reservations for new FX product activity.
* General & administrative expenses fell: $14,097 (Q2 2025) vs $17,201 (Q2 2024) - management has taken cost-control actions and reduced some overhead items.
* Interest and related-party interest expense declined vs prior-year periods (interest expense $812 in Q2 2025 vs $1,719 Q2 2024; related-party interest essentially zero in Q2 2025) - some relief on cash interest outflows.

Negative aspects and risks (income statement drivers and red flags)
* Massive losses driven by financing items: the headline net loss is dominated by change-in-fair-value and losses on settlement of debt - Q2 included (Change in fair value of notes/warrants/derivs) $(46,078) and Loss on settlement of notes payable $(22,458). These are large, volatile, non-operating items that swamp operational results.
* Extreme negative gross margin on product: Q2 cost of revenue $26,912 vs revenue $54 - per-unit economics not demonstrated; scale not yet achieved.
* Substantial recurring operating losses: loss from operations $(48,108) in Q2 and $(91,939) YTD; R&D and G&A remain material as company attempts commercialization.
* High leverage and contingent liabilities: warrant liabilities $51,033 (current) + related-party warrant liabilities $3,756; notes payable carrying value $28,033 - convertible features, anti‑dilution clauses, and embedded derivatives create unpredictable P&L swings.
* Working capital & going-concern: filing flags "substantial doubt" about ability to continue as a going concern; negative working capital noted ($146.0M) and accumulated deficit $4,449,300.
* Governance & control issues: material weaknesses in internal control over financial reporting disclosed; SEC Wells Notices to company and certain executives noted in subsequent events - these raise legal, operational and reputation risks that can affect costs and access to capital.

Key operational metrics & other facts to watch (from the filing)
* Inventory reserve increased: inventory net $23,103 with inventory reserve $7.1M (June 30, 2025).
* Deposits (R&D/production/vendor): $33,424 - large vendor exposure and capital commitments in process.
* Customer deposits ~ $3.2M (June 30, 2025) - some pre-orders but still small relative to production needs.
* SPA commitments: as of June 30, 2025 SPA commitments totaled $655.5M (of which $449.3M funded; $206.2M remaining), but large portions expired unfunded post‑period; subsequent financings and warrant exercises generated cash post-period.
* Cash burn: net cash used in operating activities $43,608 (six months 2025) - continued significant cash consumption despite financing inflows.

Bottom line / short take
Faraday Future is still pre-scale: management is investing in product and factory build-out while depending on complex, debt-and-warrant financings to fund operations. The income statement is dominated by non-cash, financing-driven volatility (fair value adjustments and settlement losses), while core product revenue remains immaterial vs cost of goods sold. Recent cash inflows improved the cash balance, but substantial doubt about going concern remains, internal control weaknesses and SEC scrutiny increase execution risk. Investors should treat operating results and EPS as heavily distorted by financing accounting; the real question is whether the company can secure durable financing, improve unit economics as production ramps, and resolve governance and control issues.

If you want, I can extract a one‑page P&L-only scoreboard or prepare a short risks-and-catalysts checklist for the next 12 months.